Maxcyte, Inc.
MXCT· Nasdaq
Released Nov 9, 2022, after the close
10-Q filed Nov 9, 2022, 40 days after period end · 0001558370-22-017204
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Net Income | -$6.43M | -$2.68M | -$3.10M |
| EPS Diluted | -$0.06 | -$0.03 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Maxcyte, Inc. · CIK 1287098 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2022 · filed Nov 9, 2022 · 40 d after period end
+13.6% from the close of Nov 9, 2022 to the close of Nov 14, 2022, the first after the release.